Delivery Order SPE2DB22D3301-SPE2DB25FZ1GR
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $6,344.46 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Aranest 40 MCG/0.4 ML syringes. This firm fixed-price, non-set-aside contract is scheduled for ultimate completion on September 18, 2025, with performance to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. This...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,728.48 on July 22, 2025, for the supply of Aranespâ„¢ 40 mcg/0.4 mL syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 23, 2025, with performance occurring at the vendor's Conshohocken, Pennsylvania facility. The award carries no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete in...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,373.84 on August 25, 2025, for the supply of Aranespbin 150 mcg/0.3 mL syringes under a competitive, non-set-aside contract. The work is scheduled for completion by August 26, 2025, with performance taking place at the company's corporate office location in Conshohocken, Pennsylvania. This award is funded through the Defense Logistics Agency's Medical Supply Chain division and represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,483.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Aranespß 60 mcg/0.3 mL syringes on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-set-aside contract represents a small-value pharmaceutical supply transaction fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. The delivery order falls under AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a $3,647.09 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Aranespâ„¢ 500 micrograms per 1 milliliter syringes. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, a $999,999,999.00 prime vendor agreement valued through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $4,502.24 to AmerisourceBergen Drug Corp for Aranesp 40 mcg/0.4 mL syringes on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania. This award represents a continuation of the company's role as a...
- The Defense Logistics Agency awarded a $9,393.31 delivery order to AmerisourceBergen Drug Corp for Aransesp 500 mcg/1 ml syringes on September 9, 2025, with completion targeted for September 10, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 9, 2025, for Persaris ER 90 mg syringe kits valued at $8,527.44. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of September 4, 2025. The contract calls for delivery of Tezspire 210 mg/1.91 ml pen injectors, a specialty pharmaceutical product for respiratory conditions. This is a firm fixed-price, competitively awarded delivery order with no...
- The Defense Logistics Agency (DLA) awarded a $3,794.64 delivery order to AmerisourceBergen Drug Corp for ARANESP 200 MCG/0.4 ML syringes on May 21, 2025, with completion scheduled for May 22, 2025. This firm fixed-price contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The order was competitively awarded with no set-aside designation....